Sarcoidosis-associated fatigue: an often forgotten symptom

  title={Sarcoidosis-associated fatigue: an often forgotten symptom},
  author={Shailendra Kapoor},
  journal={Expert Review of Clinical Immunology},
  pages={109 - 110}
  • S. Kapoor
  • Published 2013
  • Medicine
  • Expert Review of Clinical Immunology
I read with great interest the recent article by Baughman and Nunes [1]. An aspect of sarcoidosis that is often forgotten is disease-associated fatigue and lassitude. Younger individuals afflicted with sarcoidosis report more fatigue than older patients [2]. Moreover, fatigue is more common in females than in males. Nearly 47% of male patients with sarcoidisis have decreased testosterone levels [3]. This further contributes to sarcoidosis-associated fatigue. Similarly, sarcoidoisis may result… Expand
5 Citations

Topics from this paper

Current best practice in the management of pulmonary and systemic sarcoidosis
The principles of managing sarcoidosis are discussed, including standards of care relating to pulmonary disease as well as recent advances relating to the detection and treatment of extrapulmonary manifestations. Expand
Lung sarcoidosis in children: update on disease expression and management
In the included children, mostly of Afro-Caribbean and Sub-Saharan origin, sarcoidosis seems severe, with multi-organic involvement and foreground general symptoms, and common prognosis factors are not suitable in paediatric patients. Expand
Paediatric sarcoidosis.
This review aims to provide an overview of current knowledge on sarcoidosis in children, providing a summary of the data available from cohort studies on the presentation, the management and the evolution of the disease in this specific population. Expand
Benefits of physical training in patients with idiopathic or end-stage sarcoidosis-related pulmonary fibrosis: a pilot study.
A 12-week physical training program improved or maintained exercise capacity in patients with IPF (despite disease progression) or fibrotic sarcoidosis and the results from this pilot study could be used to design prospective studies aimed at answering lingering questions about exercise training in Patients with these progressive, incurable conditions. Expand


Fatigue in patients with sarcoidosis, compared with the general population.
Compared with the general population, young sarcoidosis patients are especially affected by fatigue, and the comparison to norm data is highly recommended for the evaluation of age and gender differences. Expand
Fatigue is associated with quality of life in sarcoidosis patients.
If these results were to be replicated in a prospective study, fatigue as measured by the FAS could be a good indicator of QOL in sarcoidosis patients. Expand
Armodafinil for sarcoidosis-associated fatigue: a double-blind, placebo-controlled, crossover trial.
Armodafinil treatment led to a significant reduction in fatigue in sarcoidosis patients, seen even in patients who did not have excessive daytime somnolence. Expand
Hypogonadism in male outpatients with sarcoidosis.
Non-significant relationships were found between sex hormones, clinical outcomes and C-reactive protein in patients with sarcoidosis, and poor inspiratory and quadriceps muscle function, exercise intolerance, diminished vitality and depressed mood were not related to hypogonadism in these patients. Expand
Reduced Th2 cytokine production by sarcoidosis patients in clinical remission with chronic fatigue
In chronically fatigued sarcoidosis patients in clinical remission, a cytokine/chemokine profile is found which is suggestive for a less competent Th2 counterbalancing capacity, that may contribute to the persistence of chronic fatigue. Expand
An elderly patient with sarcoidosis manifesting panhypopituitarism with central diabetes insipidus.
Diffuse damage of anterior pituitary combined with hypothalamic involvement leading to central diabetes insipidus is a rare manifestation in such elderly patients with neurosarcoidosis. Expand
Double-blind, randomized trial of dexmethylphenidate hydrochloride for the treatment of sarcoidosis-associated fatigue.
Treatment with d-MPH was associated with a significant improvement in sarcoidosis-associated fatigue and was well tolerated. Expand
Therapy for sarcoidosis: evidence-based recommendations
A stepwise approach to treatment of sarcoidosis is outlined, based on available evidence, which shows that other agents have been shown to be steroid sparing, and therefore useful for long-term management. Expand
Armodafinil for sarcoidosisassociated fatigue: a double-blind, placebo-controlled